SYS ONLINE
//decoded-longevity
[PORTFOLIO]

A selective roster. Announced only when cleared.

A selective practice. The firm publishes the practice areas it operates within and the criteria it applies — brand identities are announced only when contractually cleared and regulatorily ready.

[STANDING NOTE]

Brand identities are not displayed on this page. That is a structural choice, not an omission. The firm represents brands under contracts that often restrict public mention until the regulatory dossier in the launch market clears, until channel exclusivity is operative, or until the brand owner authorises disclosure.

Where Decoded can stand behind a public association, the association will appear here. Until then, the firm is described by the practice areas it operates within, the criteria it applies, and the documented commitments it makes — not by a logo wall.

Principals evaluating Decoded in confidence are welcome to request a private brand record under NDA via the partner inbox.

[PRACTICE AREAS]

Six practice areas.

Each tile is a thesis page — opportunity, regulatory landscape, channel landscape, and the criteria the firm applies.

Partner inquiryAbout the firm
// faq

Frequently asked, by practice area.

  1. Q01

    What does Decoded look for in a premium supplements brand?

    Manufacturing site holding ISO 22716 or PIC/S GMP with current third-party audits, an active-ingredient profile that survives HSA and BPOM scrutiny without retrofit, dossier-grade evidence behind every claim, and a pricing architecture that holds across the bloc. Mass FMCG positioning is out of scope.

  2. Q02

    What does Decoded look for in functional food and beverage?

    HACCP and ISO 22000 manufacturing, claim language written for the regulator before it is written for the customer, halal posture decided at formulation rather than retrofitted at audit, and a channel mix that respects pharmacy and clinic-led distribution alongside the licensed e-commerce slice that does not erode brand pricing.

  3. Q03

    What does Decoded look for in cosmeceuticals?

    ASEAN Cosmetic Directive notification readiness across the six markets, an actives list that survives the 39th and 40th ACD revisions without rework, halal-status discipline for the Indonesian market, and a channel posture that lands the brand in dermatology clinics and premium pharmacy chains rather than the mass beauty corridor.

  4. Q04

    What does Decoded look for in medical devices?

    ISO 13485 quality management, current registrations in at least one demanding regulator (FDA, TGA, MFDS, PMDA, EU MDR), a clinical-evidence pack the firm can defend in front of HSA's MDB and BPOM's medical device division, and post-market vigilance commitments named in the contract template — not handle-later.

  5. Q05

    What does Decoded look for in longevity?

    An evidence-led posture on actives and protocols, a clear distinction between cosmetic, supplement, and clinical-equipment claims (each governed by a different regulator across the bloc), and a clinic-led channel strategy that respects the practitioner audience the category is sold through.

  6. Q06

    What does Decoded look for in clinical equipment?

    Device classification clarity per market, ISO 13485 manufacturing and current third-party audits, a clinical-evidence pack appropriate to the device class, and a service and warranty model that survives the absence of in-market technical depth in some of the six jurisdictions.